UPCC 07422 Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients
Enrolling By Invitation
99 years or below
All
Phase
N/A
72 participants needed
1 Location
Brief description of study
Please refer to Protocol Section 2.0, Study Objectives. Please refer to Protocol Sections 8.2, Primary Endpoints. Please refer to Protocol Sections 8.3, Secondary Endpoints.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
11 Oct 2024.
Study ID: 851615
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
